Investor relations
Our science-led strategy is key to delivering long-term value for patients, employees and shareholders.
NYSE: MRK
April 23, 2025 9:19 am ET
Delayed at least 20 minutes
Latest news, events & financials
April 24, 2025
May 27, 2025
June 02, 2025
July 29, 2025
Q1 2025 Earnings Call
Dial: (800) 369-3351 (U.S. and Canada Toll-Free) or (517) 308-9448 (International)
Access Code: 9818590
Our pipeline shows our relentless pursuit of the next breakthrough.
Phase II programs
80+
Phase III programs
30+
Under review
10+
Our leadership
Our deep bench of talent has the knowledge, commitment and expertise to successfully execute on our innovation strategy.
Sustainability
Supporting the future of our business and the health and well-being of patients, people and communities around the world.
Download our Sustainability financing documents:
